
Global & Saudi Arabia Cancer Therapeutics Market to 2031
Description
The expansion of the cancer therapeutics market in Saudi Arabia is propelled by a rising cancer incidence, enhanced healthcare infrastructure, and a growing elderly population. The country has witnessed an increase in cancer cases and related mortality rates. According to GLOBOCAN 2020, approximately 27,885 new cancer cases were reported, with projections indicating a rise to 60,429 cases by 2040. The report Rights and Wellbeing of Older Persons in Saudi Arabia estimates that the population aged 60 and above will increase fivefold between 2020 and 2050, growing from 2 million (5.9% of the population) to 10.5 million (23.7%). Furthermore, those aged 80 and over are expected to reach 1.6 million, accounting for 4% of the total population by 2050. Factors such as increased tobacco consumption and unhealthy dietary habits further contribute to the elevated cancer risk in the Saudi population.
The Saudi government has made substantial investments in healthcare, with a strong focus on cancer treatment. The Vision 2030 initiative emphasizes healthcare enhancements, including expanding access to cutting-edge cancer therapies. Leading institutions like the King Faisal Specialist Hospital and Research Centre are at the forefront of cancer research and treatment, providing patients with access to advanced therapeutic options.
The Saudi government has made substantial investments in healthcare, with a strong focus on cancer treatment. The Vision 2030 initiative emphasizes healthcare enhancements, including expanding access to cutting-edge cancer therapies. Leading institutions like the King Faisal Specialist Hospital and Research Centre are at the forefront of cancer research and treatment, providing patients with access to advanced therapeutic options.
Table of Contents
100 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Data Triangulation and Validation:
- 4. Saudi Arabia Cancer Therapeutics Market Landscape
- 4.1 Overview
- 4.2 Ecosystem Analysis
- 4.2.1 List of Vendors in the Value Chain
- 5. Cancer Therapeutics Market Key Market Dynamics
- 5.1 Cancer Therapeutics Market – Key Market Dynamics
- 5.2 Market Drivers
- 5.3 Market Restraints
- 5.4 Market Opportunities
- 5.5 Future Trends
- 5.6 Impact of Drivers and Restraints
- 6. Saudi Arabia Cancer Therapeutics Market – Analysis
- 6.1 Saudi Arabia Cancer Therapeutics Market Revenue (US$ Million), 2021–2031
- 6.2 Saudi Arabia Cancer Therapeutics Market Revenue and Forecast Analysis
- 7. Saudi Arabia Cancer Therapeutics Market Analysis – by Therapy Types
- 7.1 Saudi Arabia Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types
- 8. Saudi Arabia Cancer Therapeutics Market Analysis – by Indications
- 8.1 Saudi Arabia Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications
- 9. Saudi Arabia Cancer Therapeutics Market Analysis – by Distribution Channel
- 9.1 Saudi Arabia Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel
- 10. Competitive Landscape
- 10.1 Heat Map Analysis by Key Players
- 10.1 Company Positioning and Concentration
- 11. Industry Landscape
- 11.1 Overview
- 11.2 Market Initiative
- 11.2 Partnerships and Collaborations
- 11.2 Other Developments
- 12. Company Profiles
- 12.1 Bristol-Myers Squibb Co
- 12.1. 1 Key Facts
- 12.1. 2 Business Description
- 12.1. 3 Products and Services
- 12.1. 4 Financial Overview
- 12.1. 5 SWOT Analysis
- 12.1. 6 Key Developments
- 12.2 AbbVie Inc
- 12.2. 1 Key Facts
- 12.2. 2 Business Description
- 12.2. 3 Products and Services
- 12.2. 4 Financial Overview
- 12.2. 5 SWOT Analysis
- 12.2. 6 Key Developments
- 12.3 Johnson & Johnson
- 12.3. 1 Key Facts
- 12.3. 2 Business Description
- 12.3. 3 Products and Services
- 12.3. 4 Financial Overview
- 12.3. 5 SWOT Analysis
- 12.3. 6 Key Developments
- 12.4 F. Hoffmann-La Roche Ltd
- 12.4. 1 Key Facts
- 12.4. 2 Business Description
- 12.4. 3 Products and Services
- 12.4. 4 Financial Overview
- 12.4. 5 SWOT Analysis
- 12.4. 6 Key Developments
- 12.5 Pfizer Inc
- 12.5. 1 Key Facts
- 12.5. 2 Business Description
- 12.5. 3 Products and Services
- 12.5. 4 Financial Overview
- 12.5. 5 SWOT Analysis
- 12.5. 6 Key Developments
- 12.6 AstraZeneca Plc
- 12.6. 1 Key Facts
- 12.6. 2 Business Description
- 12.6. 3 Products and Services
- 12.6. 4 Financial Overview
- 12.6. 5 SWOT Analysis
- 12.6. 6 Key Developments
- 12.7 Merck KGaA
- 12.7. 1 Key Facts
- 12.7. 2 Business Description
- 12.7. 3 Products and Services
- 12.7. 4 Financial Overview
- 12.7. 5 SWOT Analysis
- 12.7. 6 Key Developments
- 12.8 Novartis AG
- 12.8. 1 Key Facts
- 12.8. 2 Business Description
- 12.8. 3 Products and Services
- 12.8. 4 Financial Overview
- 12.8. 5 SWOT Analysis
- 12.8. 6 Key Developments
- 12.9 Astellas Pharma Inc
- 12.9. 1 Key Facts
- 12.9. 2 Business Description
- 12.9. 3 Products and Services
- 12.9. 4 Financial Overview
- 12.9. 5 SWOT Analysis
- 12.9. 6 Key Developments
- 12.10 Eli Lilly and Co
- 12.10. 1 Key Facts
- 12.10. 2 Business Description
- 12.10. 3 Products and Services
- 12.10. 4 Financial Overview
- 12.10. 5 SWOT Analysis
- 12.10. 6 Key Developments
- 13. Appendix
- 13.1 About Business Market Insights
- 13.2 List of Abbreviations
- TABLE OF TABLES
- Table 1. Saudi Arabia Cancer Therapeutics Market Segmentation
- Table 2. List of Vendors
- Table 3. Saudi Arabia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)
- Table 4. Saudi Arabia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)
- Table 5. Saudi Arabia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types
- Table 6. Saudi Arabia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types
- Table 7. Saudi Arabia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications
- Table 8. Saudi Arabia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
- Table 9. Saudi Arabia Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel
- Table 10. Saudi Arabia Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel
- Table 11. List of Abbreviations
- TABLE OF FIGURES
- Figure 1. Impact Analysis of Drivers and Restraints
- Figure 2. Saudi Arabia Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031
- Figure 3. Heat Map Analysis by Key Players
- Figure 4. Company Positioning and Concentration
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.